- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in EBV Vaccines
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-25
DOI
10.3389/fonc.2019.00104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein–Barr virus strain heterogeneity impairs human T-cell immunity
- (2018) Ana Cirac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
- (2018) Joost Snijder et al. IMMUNITY
- Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
- (2018) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo
- (2018) Viktor Schneidt et al. LEUKEMIA
- Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames
- (2018) Maja Bencun et al. NUCLEIC ACIDS RESEARCH
- Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
- (2018) Hua Zhang et al. Nature Microbiology
- Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
- (2018) Jia Chen et al. Nature Microbiology
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen–Containing Particles
- (2017) María López-Montañés et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children
- (2017) Carrie B Coleman et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains
- (2017) Yanping Zhang et al. VACCINE
- Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
- (2017) Anatoliy Shumilov et al. Nature Communications
- Marek’s disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation
- (2016) Marla C. McPherson et al. VACCINE
- Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
- (2016) Xinle Cui et al. VACCINE
- Structural basis for Epstein–Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins
- (2016) Karthik Sathiyamoorthy et al. Nature Communications
- Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
- (2016) Elizabeth M. Perez et al. Oncotarget
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
- (2016) Jill M. Brooks et al. PLoS Pathogens
- Self-assembling protein nanoparticles in the design of vaccines
- (2016) Jacinto López-Sagaseta et al. Computational and Structural Biotechnology Journal
- The Immunology of Epstein-Barr Virus–Induced Disease
- (2015) Graham S. Taylor et al. Annual Review of Immunology
- Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells
- (2015) X. Yu et al. BLOOD
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
- (2015) Alexander M. Price et al. PLoS Pathogens
- Varicella zoster virus infection
- (2015) Anne A. Gershon et al. Nature Reviews Disease Primers
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines
- (2014) Carrie B. Coleman et al. JOURNAL OF VIROLOGY
- Efficient replication of Epstein–Barr virus in stratified epithelium in vitro
- (2014) Rachel M. Temple et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assembly and Architecture of the EBV B Cell Entry Triggering Complex
- (2014) Karthik Sathiyamoorthy et al. PLoS Pathogens
- Epstein-Barr virus and nasopharyngeal carcinoma
- (2014) Lawrence S. Young et al. Chinese Journal of Cancer
- Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
- (2013) M. Green et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Detection of Epstein-Barr virus-specific memory CD4+T cells using a peptide-based cultured enzyme-linked immunospot assay
- (2013) Sandra A. Calarota et al. IMMUNOLOGY
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response
- (2013) R. J. M. Abbott et al. JOURNAL OF IMMUNOLOGY
- A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine
- (2013) Xinle Cui et al. VACCINE
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
- (2013) Javier G. Ogembo et al. Cell Reports
- An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions
- (2012) Aaron Arvey et al. Cell Host & Microbe
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students
- (2012) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA
- (2012) S. Pavlova et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology
- (2012) Emily Heath et al. PLoS Pathogens
- The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
- (2012) Simon Jochum et al. PLoS Pathogens
- A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
- (2011) W. K. Chia et al. ANNALS OF ONCOLOGY
- Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
- (2011) H. M. Long et al. JOURNAL OF IMMUNOLOGY
- Fusion of Epstein-Barr Virus with Epithelial Cells Can Be Triggered by v 5 in Addition to v 6 and v 8, and Integrin Binding Triggers a Conformational Change in Glycoproteins gHgL
- (2011) L. S. Chesnokova et al. JOURNAL OF VIROLOGY
- A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
- (2011) R. Ruiss et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
- (2010) S.-D. Ma et al. JOURNAL OF VIROLOGY
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
- (2009) Till Strowig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T Cell–Mediated Control of Epstein‐Barr Virus Infection in Humanized Mice
- (2009) Misako Yajima et al. JOURNAL OF INFECTIOUS DISEASES
- Primary B-Cell Infection with a BALF4 Epstein-Barr Virus Comes to a Halt in the Endosomal Compartment yet Still Elicits a Potent CD4-Positive Cytotoxic T-Cell Response
- (2009) B. Neuhierl et al. JOURNAL OF VIROLOGY
- AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome
- (2009) M. Kalla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8
- (2009) L. S. Chesnokova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells
- (2009) Jianqiao Xiao et al. VIROLOGY
- Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
- (2008) C. Gurer et al. BLOOD
- Risk of Herpes Zoster in Adults Immunized with Varicella Vaccine
- (2008) Sophie Hambleton et al. JOURNAL OF INFECTIOUS DISEASES
- A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses
- (2008) Misako Yajima et al. JOURNAL OF INFECTIOUS DISEASES
- Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles
- (2008) D. Adhikary et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search